LD-2 disclosure · 3rd Quarter - Report
OPIANT PHARMACEUTICALS
Income$50Kfee reported
Client
- Description
- Pharmaceutical company; develops medicines for the treatment of addictions and overdose
- Location
- California · United States of America
Registrant
- Description
- lobby firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
SOR grant language changes, allowable expenses under the SOR grant
LobbyistsJACOB JACKSON · TESS BETTLER
TargetedHealth & Human Services, Dept of (HHS)